Literature DB >> 879831

Controlled trial of azathioprine in treatment of steroid-responsive nephrotic syndrome of childhood.

T M Barratt, J S Cameron, C Chantler, R Counahan, C S Ogg, J F Soothill.   

Abstract

A controlled trial of azathioprine treatment of steroid-responsive frequent-relapsing nephrotic syndrome of childhood failed to show a therapeutic effect on the stability of remission after withdrawal of corticosteroid treatment.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 879831      PMCID: PMC1544692          DOI: 10.1136/adc.52.6.462

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  5 in total

1.  Sterility and testicular atrophy related to cyclophosphamide therapy.

Authors:  K F Fairley; J U Barrie; W Johnson
Journal:  Lancet       Date:  1972-03-11       Impact factor: 79.321

2.  Controlled trial of cyclophosphamide in steroid-sensitive relapsing nephrotic syndrome of childhood.

Authors:  T M Barratt; J F Soothill
Journal:  Lancet       Date:  1970-09-05       Impact factor: 79.321

3.  Controlled trial of azathioprine in children with nephrotic syndrome. A report for the international study of kidney disease in children.

Authors:  M Abramowicz; H L Barnett; C M Edelmann; I Greifer; O Kobayashi; G C Arneil; B A Barron; G Gordillo-P; N Hallman; H A Tiddens
Journal:  Lancet       Date:  1970-05-09       Impact factor: 79.321

4.  Albumin excretion as a measure of glomerular dysfunction in children.

Authors:  T M Barratt; P N McLaine; J F Soothill
Journal:  Arch Dis Child       Date:  1970-08       Impact factor: 3.791

5.  HLA antigens and atopic features in steroid-responsive nephrotic syndrome of childhood.

Authors:  P D Thomson; C R Stokes; T M Barratt; M W Turner; J F Soothill
Journal:  Lancet       Date:  1976-10-09       Impact factor: 79.321

  5 in total
  10 in total

Review 1.  Corticosteroid therapy for nephrotic syndrome in children.

Authors:  Deirdre Hahn; Elisabeth M Hodson; Narelle S Willis; Jonathan C Craig
Journal:  Cochrane Database Syst Rev       Date:  2015-03-18

2.  Nephrotic syndrome of childhood: malaria therapy reconsidered.

Authors:  T M Barratt
Journal:  Arch Dis Child       Date:  1979-11       Impact factor: 3.791

3.  Management and diagnosis of children with the nephrotic syndrome.

Authors: 
Journal:  Br Med J       Date:  1977-10-29

Review 4.  The treatment of minimal change nephrotic syndrome: lessons learned from multicentre co-operative studies.

Authors:  J Brodehl
Journal:  Eur J Pediatr       Date:  1991-04       Impact factor: 3.183

Review 5.  Mycophenolate mofetil therapy in frequently relapsing steroid-dependent and steroid-resistant nephrotic syndrome of childhood: current status and future directions.

Authors:  Asha Moudgil; Arvind Bagga; Stanley C Jordan
Journal:  Pediatr Nephrol       Date:  2005-06-24       Impact factor: 3.714

Review 6.  The management of idiopathic nephrotic syndrome in children.

Authors:  Elisabeth Hodson
Journal:  Paediatr Drugs       Date:  2003       Impact factor: 3.022

Review 7.  Immunosuppressive therapy in the nephrotic syndrome in children.

Authors:  R S Trompeter
Journal:  Pediatr Nephrol       Date:  1989-04       Impact factor: 3.714

8.  Recurrent nephrotic syndrome after transplantation: early treatment with plasmaphaeresis and cyclophosphamide.

Authors:  P Cochat; A Kassir; S Colon; C Glastre; B Tourniaire; B Parchoux; X Martin; L David
Journal:  Pediatr Nephrol       Date:  1993-02       Impact factor: 3.714

9.  Efficacy and acceptability of immunosuppressive agents for pediatric frequently-relapsing and steroid-dependent nephrotic syndrome: A network meta-analysis of randomized controlled trials.

Authors:  Liping Tan; Shaojun Li; Haiping Yang; Qing Zou; Junli Wan; Qiu Li
Journal:  Medicine (Baltimore)       Date:  2019-05       Impact factor: 1.817

10.  Non-corticosteroid immunosuppressive medications for steroid-sensitive nephrotic syndrome in children.

Authors:  Nicholas G Larkins; Isaac D Liu; Narelle S Willis; Jonathan C Craig; Elisabeth M Hodson
Journal:  Cochrane Database Syst Rev       Date:  2020-04-16
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.